Table Of Content

Author Index ABNEY, E. see ZHENG, R.Q.H. CarETTO, A. see BAGNASCO, M. ABRAMOWICZ, D. see DOUTRELEPONT, J.M. CARMAN, K.L. see KOWANKO, I.C. ABRAMOWICZ, D. see WiSSING, M. CASSANI, F. see Fusconti, M. ACHTMAN, M. see JAHN, S. CASSELLI, A. see Fusconi, M. Apams, E.M. see Cuo, S.-W. CHANG, T.T. see Lei, H.Y. Apu, D. see MoRLAND, C. CHATURVEDI, U.C. see BHARADWAS, M. AL-AZZAWI, F. see GALLAGHER, G. Cuo, S.-W., OGuesBy, T.J., Hsi, B.-L., ADAMs, E.M. & ATKINSON, J.P. Avpers, M.P. see Witt, C.S. Characterization of three monoclonal antibodies to membrane co- ANGELINI, G. see MANTOVANI, V. factor protein (MCP) of the complement system and quantification of APPELBERG, R., PEpRosA, J.M. & Sitva, M.T. Host and bacterial MCP by radioassay, 257 control of the Mycobacterium avium-induced chronic peritoneal CHOLLET-MartTIN, S., STAMATAKIS, G., BAILLY, S., MERRY, J.P. & granulocytosis in mice, 231 GOuGEROT-PociDALO, M.A. Induction of tumour necrosis factor- ARAKAWA, M. see Narita, I. alpha during haemodialysis. Influence of the membrane type, 329 ATKINS, R.M. see HOLLANDER, A.P. Cuu, C.Q. see ZHENG, R.Q.H. ATKINSON, J.P. see CHo, S.-W. COHEN TERVAERT, J.W. see BRouwER, E. AULD, P.A.M. see VEBER, M.B. CoLeE, P. see WARREN, R.P. ConraD, A.K. see ROHRBACH, M.S. BaGNasco, M., CaRETTO, A., Ouive, D., Pepini, B., CANONICA, G.W. & Cooke, A. Editorial review: Is there restricted T cell receptor usage in BETTERLE, C. Expression of intercellular adhesion molecule-! autoimmune disease? 345 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but CorRAZZA, G.R. see MANTOVANI, V. not in Graves’ disease or papillary thyroid cancer, 309 Cotter, T.G. see MARTIN, S.J. BAILLY, S. see CHOLLET-MartTIN, S. COUuTINHO, S.G. see MENDONGA, S.C.F. BAKKER, N.P.M. see "T Hart, B.A. Cox, R.A. see Doo.ey, D.P. BALLARDINI, G. see FUSCONI, M. CrovatTto, M. see De PAO, P. BARBONI, P. see MANTOVANI, V. CUNNINGHAM-RUNDLES, S. see VEBER, M.B. BASAGLIA, G. see DE PAOLt, P. BATTISTIN, S. see DE PAOLI, P. D’AmELIO, R.D. see LE MOLI, S. BEHAN, P.O. see Morrison, L.J.A. Dana, M.R. see VAN Laar, J.M. BEHAN, W.H.M. see Morrison, L.J.A. Das, K.M. see EBerT, E.C. BERRIH-AKNIN, S. see GUIGOU, V. Davies, A. see ROONEY, I.A. BERTOVICH, M.J. see MACDERMOTT, R.P. Davies, B.H. see JONES, K.P. BETTERLE, C. see BAGNASCO, M. Davies, M. see Rooney, I.A. BevAN, D.H. see ToozeE, J.A. Davis, M.R. see MANNING, L.S. BHARADWAS, M., KHANNA, N., MatHur, A. & CHATURVEDI, U.C. Deacon, E.M., MATTHEWS, J.B., Potrs, A.J. C., HAMBURGER, J., Effect of macrophage-derived factor on hypoferraemia induced by MaGeeD, R.A. & JEFFERIS, R. Expression of rheumatoid factor Japanese encephalitis virus in mice, 215 associated cross-reactive idiotopes by glandular B cells in Sjégren’s BuatTT, B.D. see EBert, E.C. syndrome, 280 BIANCHI, F.B. see FuscoNi, M. Deane, D.L., Harvey, E. & STEEL, C.M. Differential effects of CD45 BIANCONE, L., BoiRIVANT, M., Fais, S., Ricci, G.L., PAGANELLI, R. & CD45R and CD45R0 monoclonal antibodies in modulating human B PALLONE, F. Serum immunomodulatory factors in gastrointestinal cell activation, 175 diseases. A 30-50-kD serum fraction in Crohn’s disease capable of Deem, R.L., SHANAHAN, F. & TARGAN, S.R. Triggered human mucosal modulating lymphocyte activation, 401 T cells release tumour necrosis factor-alpha and interferon-gamma BLACK, M. see HAMILTON, F. which kill human colonic epithelial cells, 79 BoIRIVANT, M. see BIANCONE, L. DELFINO, L. see MANTOVANI, V. BoTMAN, C.A. D. see "T Hart, B.A. DEMAINE, A.G. see WONG, S. Boyer, V., BROLY, H., SOUCHE, S., MADAULE, P., RossiER, H., ZAGURY, Denis, M. Modulation of Mycobacterium avium growth in vivo by D. & DesGRances, C. Characterization and large production of cytokines: involvement of tumour necrosis factor in resistance to human monoclonal antibodies against the HIV-1 envelope, 452 atypical mycobacteria, 466 Bral, M. see WURZNER, R. DENMAN, A.M. see PELTON, B.K. BRANDAU, D.T., O’DONNELL, R. & KimMeL-Truitt, V.L. Lack of De Paoui, P., GENNARI, D., MARTELLI, P., BASAGLIA, G., CROVATTO, binding between cryoimmunoglobulins, immunoglobulins and fibro- M., BatTisTIN, S. & SANTINI, G. A subset of yd lymphocytes is nectin: implications for immune complex vasculitis, 58 increased during HIV-1 infection, 187 BRANDTZAEG, P. see MOLLER, F. DESGRANGES, C. see BOYER, V. BRANDTZAEG, P. see NILSSEN, D.E. De Vries, R.R. P. see VAN Laar, J.M. BREEDVELD, F.C. see VAN Laar, J.M. Dieppe, P.A. see HOLLANDER, A.P. BROLY, H. see Boyer, V. Doo ey, D.P., Cox, R.A. & Looney, D.J. Effect ofa recombinant HIV Brookes, R.H. see OxLey, J.D. gp160 vaccine on monokine production, 192 Brouwer, E., COHEN TERVAERT, J.W., Horst, G., HurremMa, M.G., DouTRELEPONT, J.M., Moser, M., Leo, O., ABRAMOWICZ, D., VANDER- VAN DER GIESSEN, M., LimpurG, P.C. & KALLENBERG, C.G.M. Pre- HAEGEN, M.L., URBAIN, J. & GOLDMAN, M. Hyper IgE in stimulatory dominance of IgG! and IgG4 subclasses of anti-neutrophil cytoplas- graft-versus-host disease: role of interleukin-4, 133 mic antibodies (ANCA) in patients with Wegener’s granulomatosis Dracu, J., GATTRINGER, C. & Huser, H. Expression of the neural cell and clinically related disorders, 379 adhesion molecule (CD56) by human myeloma cells, 418 BuTcuHer, D. see WatTTs, R.A. Ducos, J. see VENDRELL, J.P. CANONICA, G.W. see BAGNASCO, M. EAGLING, S. see RAYNES, J.G. Capper, S.J. see JONES, K.P. Eastwoop, D.M. see HOLLANDER, A.P. 520 Author Index Epert, E.C., BHATT, B.D., Liu, S. & Das, K.M. Induction of suppressor HENDERSON, D., SHELDON, J., RicHes, P. & Hosss, J.R. Cytokine cells by Mycobacterium paratuberculosis antigen in inflammatory induction of neoprotein production, 479 bowel disease, 320 Herva, E. see SuRCEL, H.M. Epwarops, J.H. see Jones, K.P. HEYMANNS, J. see SCHUER, U. E.son, C.J. see HOLLANDER, A.P. HIRAMINE, C. see ITOH, M. Emiuig, D. see Guicou, V. Hosss, J.R. see HENDERSON, D. HoGarTH, P.M. see JAZWINSKA, E.C. Hojo, K. see ITou, M. Fas, S. see BIANCONE, L. HOLLANDER, A.P., ATKINS, R.M., Eastwoop, D.M., Dieppe, P.A. & FARABEGOLI, F. see FUSCONI, M. E.son, C.J. Human cartilage is degraded by rheumatoid arthritis FARQUHARSON, M.A. see HAMILTON, F. synovial fluid but not by recombinant cytokines in vitro, 52 FARRANT, J. see Howe, H.S. HorsFALL, A.T. see WaTTS, R.A. FARRANT, J. see PELTON, B.K. Horst, G. see BRouwER, E. FELDMANN, M. see KONTIAINEN, S. Howe, H.S., So, A.K. L., FARRANT, J. & WesstTer, A.D. B. Common FELDMANN, M. see ZHENG, R.Q. H. variable immunodeficiency is associated with polymorphic markers in FERRANTE, A. see KOWANKO, L.C. the human major histocompatibility complex, 387 FERRARA, G.B. see MANTOVANI, V. Fiecp, M. see ZHENG, R.Q. H. Howie, A.J. see MORLAND, C. Hs1, B.-L. see Cuo, S.-W. FITZGERALD, P. see MACDeERMOTT, R.P. Huser, H. see Dracu, J. FLAMAND, V. see WISSING, M. HuGuet, M.F. see VENDRELL, J.P. FOuGEREAU, M. see GuiGou, V. Huitema, M.G. see BRouweR, E. Fouts, A.K. see HAMILTON, F. Hvatum, M. see MULLER, F. Frisoni, M. see MANTOVANI, V. HYLTON, W. see PELTON, B.K. FROLAND, S.S. see MOLLER, F. Fusita, T. see Iton, J. Ikepa, M., IKEDA, U., OOHARA, T., TAKEDA, K. & KANo, S. Recombi- FuKaTsu, A. see NISHIKAWA, K. nant interleukin-la« inhibits the growth of rat mesangial cells in Fumoux, F. see GuiGcou, V. culture, 149 Fuscont, M., CAssANi, F., Govoni, M., CasseLii, A., FARABEGOLI, F., IKEDA, U. see IkEDA, M. Lenzi, M., BALLARDINI, G., ZAULI, D. & BIANCHI, F.B. Anti-nuclear ILONEN, J. see SyRJALA, H. antibodies of primary biliary cirrhosis recognize 78-92-kD and 96 ISENBERG, D.A. see WATTS, R.A. 100-kD proteins of nuclear bodies, 291 IsHIOKA, C. see KIMATA, H. ISHIZAKA, A. see TOMIZAWA, K. GALLAGHER, G., AL-AzZAwl, F., WALSH, L.P. & WiLson, G. 14Cl, an Ito, Y. see NISHIKAWA, K. antigen associated with human ovarian cancer, defined using a human IToun, J., Nose, M., Fusita, T., Kato, M. & KyoGo«u, M. Expression of IgG monocloncal antibody, 92 decay-accelarating factor is reduced on hyperplastic synovial lining GALLART, T. see MUNOZ, A. cells in rhematoid synovitis, 364 GASBARRINI, G. see MANTOVANI, V. IroH, M., Hiramine, C. & Hoyo, K. A new murine model of GaTENBY, P.A. see JAZWINSKA, E.C. autoimmune orchitis induced by immunization with viable syngeneic GATTRINGER, C. see DRacu, J. testicular germ cells alone.I. Immunological and histological studies, Gennarl, D. see De PAO.t, P. 137 GOLDMAN, M. see DOUTRELEPONT, J.M. IVANYI, L., NEWMAN, H.N. & Mars, P.D. Tc ell proliferative responses GOLDMAN, M. see WISSING, M. to molecular fractions of periodontopathic bacteria, 108 Gomis, R. see MUNOZ, A. GoopsuiP, J., MALCOLM, S. & Levinsky, R.J. Evidence that X-linked JAHN, S., ScHwaB, J., HANSEN, A., HEIDER, H., SCHROEDER, C., severe combined immunodeficiency is not a differentiation defect ofT Lukowsky, A., ACHTMAN, M., MaTTues, H., KuessiG, $.T., VOLK, lymphocytes, 4 H.D., KrueGer, D.H. & Von BAEHR, R. Human hybridomas derived G6rTzeE, O. see WURZNER, R. from CD5* B lymphocytes of patients with chronic lymphocytic GOUGEROT-PocIDALO, M.A. see CHOLLET-MArTIN, S. leukaemia (B-CLL) produce multi-specific natural IgM (kappa) Govonl, M. see Fusconi, M. antibodies, 413 GriFFiTHs, D. see ROONEY, I.A. JAYNE, D.R. W. see Rossi, F. GriFFiTHS, M. see Watts, R.A. JAZWINSKA, E.C., Oxtve, C., HOGARTH, P.M., GATENBy, P.A. & GRUBECK-LOBENSTEIN, B. see ZHENG, R.Q.H. SERJEANTSON, S.W. FcyRII restriction fragment length polymor- Guicou, V., Emiuiz, D., BERRIH-AKNIN, S., FUMoux, F., FOUGEREAU, phism (RFLP): analysis in systemic lupus erythematosus and sclero- M. & Scuirr, C. Individual germinal centres of myasthenia gravis derma and evidence of an alpha gene production, 47 human thymuses contain polyclonal activated B cells that express all JEFFERIS, R. see DEACON, E.M. the Vy and V, families, 262 JENDRISAK, G.A.S. see MACDERMOTT, R.P. Jones, K.P., REYNOLDS, S.P., CAPPER, S.J., KALINKA, S., E>warps, J.H. HALLMAN, M. see StTRAYER, D.S. & Davies, B.H. Measurement of interleukin-6 in bronchoalveolar Hamapa, S. see OGAwa, T. lavage fluid by radioimmunoassay: differences between patients with HAMBURGER, J. see DEACON, E.M. interstitial lung disease and control subjects, 30 HAMILTON, F., BLACK, M., FARQUHARSON, M.A., STEWART, C. & JUNG, T. see SCHUER, U. Fou.is, A.K. Spatial correlation between thyroid epithelial cells expressing class If MHC molecules and interferon-gamma-contain- KaBAKOV, A.E., SAENKO, V.A. & POVERENNY, A.M. LDL-mediated ing lymphocytes in human thyroid autoimmune disease, 64 interaction of DNA and DNA-anti-DNA immune complexes with HANEGANE, H. see MiyAWAKI, T. cell surface, 359 HANNIGAN, B.M. see Martin, S.J. KALINKA, S. see JONES, K.P. HANSEN, A. see JAHN, S. KALLENBERG, C.G.M. see BROUWER, E. Hanson, L.A. see Nissen, D.E. KANO, S. see IKEDA, M. Happe, L. see WURZNER, R. KARLSSON, G. see NILSSEN, D.E. HARMAN, C. see WATSON, W. KARTTUNEN, R. Blood lymphocyte proliferation, cytokine secretion and Harvey, D.P. see KOwANKO, L.C. appearance of T cells with activation surface markers in cultures with Harvey, E. see Deane, D.L. Heliobacter pylori. Comparison of the responses of subjects with and Herper, H. see JAHN, S. without antibodies to H. pylori, 396 HELGELAND, L. see Nissen, D.E. KASAHARA, Y. see MIYAWAKI, T. Author Index Kato, M. see ITon, J. MATRICARDI, P.M. see LE MOLI, S. Katz, D.H. see MACDeERMOTT, R.P. Matsumoto, S. see Tomizawa, K. KAZATCHKINE, M.D. see Rossi, F. Matsuo, S. see NISHIKAWA, K. KETT, K. see NILsseN, D.E. MATTHES, H. see JAHN, S. KHANNA, N. see BHARADWAJ, M. MATTHEWS, J.B. see DEACON, E.M. KuessiG, S.T. see JAHN, S. Mazpal, G. see MARTIN, S.J. KimaTa, H., YosHipa, A., IsHioka, C. & Mikawa, H. Effect of McapaM, K.P. W. see Raynes, J.G. recombinant human erythropoietin on human IgE production in McCormick, J.A., MARKEY, G.M. & Morris, T.C. M. Lactoferrin- vitro, 483 inducible monocyte cytotoxicity for K 562 cells and decay of natural KIMMEL-TRUITT, V.L. see BRANDAU, D.T. killer lymphocyte cytotoxicity, 154 Kryono, H. see OGAwa, T. MCcGHEE, J.R. see OGawa, T. KiZAKI, T. see MORLAND, C. McaGueeE, M.L. see OGawa, T. Kosima, K. see TOMIZAWA, K. MENDONGA, S.C.F., RusseLL, D.G. & CouTiNnHo, S.G. Analysis of Kono, Y. see OGAWA, T. human T cell responsiveness to purified antigens of Leishmania: KONTIAINEN, S., TOOMATH, R., Lowper, J. & FELDMANN, M. Selective lipophosphoglycan (LPG) and glycoprotein 63 (gp 63), 472 activation of T cells in newly diagnosed insulin-dependent diabetic Me_nrI, S. see ROONEY, I.A. patients: evidence for heterogeneity of T cell receptor usage, 347 MERRIT, T.A. see STRAYER, D.S. KowANKO, I.C., FERRANTE, A., Harvey, D.P. & CARMAN, K.L. MERRY, J.P. see CHOLLET-MartTIN, S. Granulocyte-macrophage colony-stimulating factor augments neu- MICHAEL, J. see MORLAND, C. trophil killing of Torulopsis glabrata and stimulates neutrophil Mikawa, H. see Kimata, H. respiratory burst and degranulation, 225 MILLWARD, A. see WONG, S. KRUEGER, D.H. see JAHN, S. MILTENBURG, A.M.M. see VAN Laar, J.M. K YOGOKU, M. see ITon, J. Miri, P. see MANTOVANI, V. MIYAWAKI, T., KASAHARA, Y., HANEGANE, H., OnTA, K., YOKo1, T., LACHMANN, P.J. see ROONEY, I.A. YacuiE, A. & TANIGUCHI, N. Expression of CD45RO (UCHL 1) by LAFFAFIAN, I. see PIDDLESDEN, S. CD4* and CD8* T cells as a sign of in vivo activation in infectious Lal, P.K. see YAsuDA, N. mononucleosis, 447 LASSMANN, H. see PIDDLESDEN, S. Monaka, M. see MACDERMOTT, R.P. LEHMANN, D. see Witt, C.S. Moore, S. see WONG, S. Lei, H.Y., WANG, J.Y., CHANG, T.T. & WANG, C.C. Hepatitis B surface MoraGan, A. see MORLAND, C. antigen induces an early-type hypersensitivity, 210 MorGan, B.P. see PIDDLESDEN, S. LELAND, P. see Puri, R.K. MorGan, B.P. see ROONEY, I.A. Le Mout, S., MatTricarpi, P.M., QuinTi, I., STROFFOLINI, T. & MorGan, B.P. see WURZNER, R. D’AmELIO, R.D. Clonotypic analysis of human antibodies specific for MorioKA, T., NARITA, I., SHimizu, F. & Ore, T. Production by cultured Neisseria meningitidis polysaccharides A and C in adults, 460 human monocytes of mesangial cell proliferation factor(s) differing LENz1, M. see Fusconi, M. from interleukin-! and interleukin-6, 186 Leo, O. see DOUTRELEPONT, J.M. MorioKA, T. see NARITA, I. Leo, O. see WissiING, M. MorLanb, C., MICHAEL, J., Apu, D., Kizaki, T., Howie, A.J., LEVINSKY, R.J. see GOODSHIP, J. MoraGan, A. & STAINES, N.A. Anti-idiotype and immunosuppressant LimsurG, P.C. see BROUWER, E. treatment of murine lupus, 126 LININGTON, C. see PIDDLESDEN, S. Morris, T.C. M. see McCormick, J.A. Liv, S. see EBert, E.C. Morrison, L.J. A., BEHAN, W.H. M. & BEHAN, P.O. Changes in natural Lockwoop, C.M. see Rossi, F. killer cell phenotype in patients with post-viral fatigue syndrome, 441 Looney, D.J. see DooLey, D.P. Moser, M. see DOUTRELEPONT, J.M. Lowber, J. see KONTIAINEN, S. Moser, M. see WIssING, M. Lukowsky, A. see JAHN, S. MOLLER, F., FROLAND, S.S., HvatuM, M., RADL, J. & BRANDTZAEG, P. Both IgA subclasses are reduced in parotid saliva from patients with MacDermott, R.P., JENDRISAK, G.A.S., NASH, G.S., SCHREIBER, S., AIDS, 203 BERTOVICH, M.J., NAHM, M., MONAKA, M., FITZGERALD, P., KATZ, MuNoz, A., GALLART, T., ViNas, O. & Gomis, R. Increased CDS- D.H. & Marce.tettTi, J.F. Human rib bone marrow mononuclear positive B lymphocytes in type I diabetes, 304 cells spontaneously synthesize and secrete IgE in vitro, 163 MADAULE, P. see BOYER, V. Naum, M. see MAcCDermotTrt, R.P. MAGEED, R.A. see DEACON, E.M. Narita, I., Morioka, T., ARAKAWA, M., SHimizu, F. & Orrte, T. Malini, R.N. see ZHENG, R.Q.H. Monocytes secrete factors regulating glycosaminoglycan synthesis in MAKANISHI, M. see TOMIZAWA, K. mesangial cells in vitro, 497 MALCOLM, S. see GOODSHIP, J. NaritTA, I. see Morioka, T. MANDEL, F. see VEBER, M.B. Nasu, G.S. see MACDeERMOTT, R.P. MANNING, L.S., Davis, M.R. & Rosinson, B.S.W. Asbestos fibres NEWMAN, H.N. see IVANYI, L. inhibit the in vitro activity of lymphokine-activated killer (LAK) cells Nico as, J.C. see VENDRELL, J.P. from healthy individuals and patients with malignant mesothelioma, NILssen, D.E., SODERSTROM, R., BRANDTZAEG, P., KETT, K., HELGE- 85 LAND, L., KARLSSON, G., SODERSTROM, T. & HANSON, L.A. Isotype MANTOVANI, V., CORAZZA, G.R., ANGELINI, G., DELFINO, L., FRISONI, distribution of mucosal IgG-producing cells in patients with various M., Miri, P., VALENTINI, R.A., BARBONI, P., GASBARRINI, G. & IgG subclass deficiencies, 17 FERRARA, G.B. Molecular analysis of HLA-DQ A alleles in coeliac NISHIKAWA, K., FuKaTsu, A., TAMAl, H., Suzuki, N., Ito, Y., disease: lack ofa unique disease-associated sequence, 74 SAKAMOTO, N. & Matsuo, S. Formation of subepithelial dense MARCELLETTI, J.F. see MACDERMOTT, R.P. deposits in rats induced by a monoclonal antibody against the MARCHANT, A. see WISSING, M. glomerular cell surface antigen, 143 Markey, G.M. see McCormick, J.A. Nose, M. see ITon, J. Mars, P.D. see IvANy1, L. MarTELLI, P. see De PAO.t, P. OvELL, J.D. see WARREN, R.P. Martin, S.J., Mazpal, G., STRAIN, J.J., Cotter, T.G. & HANNIGAN, O’DonneELL, R. see BRANDAU, D.T. B.M. Programmed cell death (apoptosis) in lymphoid and myeloid OkEN, K. see WATSON, W. cell lines during zinc deficiency, 338 Ocawa, T., Kono, Y., McGuHeE, M.L., MCGHEE, J.R., RoBERTS, J.E., MATHUR, A. see BHARADWAJ, M. Hamapa, S. & Kiyono, H. Porphyromonas gingivalis-specific serum Author Index IgG and IgA antibodies originate from immunoglobulin-secreting RussEL_, D.G. see MENDONGA, S.C.F. cells in inflamed gingiva, 237 Oc essy, T.J. see CHo, S.-W. SAENKO, V.A. see KABAKOV, A.E. OnrTA, K. see Miyawakl, T. SAKAMOTO, N. see NISHIKAWA, K. Orre, T. see Morioka, T. SAKIYAMA, Y. see TOMIZAWA, K. Orte, T. see Narita, I. SANTINI, G. see De PAO, P. Ouive, C. see JAZWINSKA, E.C. ScuirF, C. see GuiGou, V. Otive, D. see BAGNaSCO, M. SCHREIBER, S. see MACDERMOTT, R.P. Oonara, T. see IkeDA, M. SCHROEDER, C. see JAHN, S. Orisi0, S. see WONG, S. Scuuer, U., JUNG, T., HEYMANNS, J. & RieGer, C.H.L. Imbalance of Orren, A. see WURZNER, R. CD4*CD45R* and CD4+CD29* T helper cell subsets in patients Ox ey, J.D., Brookes, R.H., RAYFIELD, L.S. & SHEPHERD, P.S. Human with atopic diseases, 25 T cell responses to B-galactosidase, 505 SCHULMAN, M. see VEBER, M.B. SCHULZE, M. see WURZNER, R. PAGANELLI, R. see BIANCONE, L. Scuwas, J. see JAHN, S. PALLONE, F. see BIANCONE, L. SEGONDY, M. see VENDRELL, J.P. PASQUALI, J.L. see URLACHER, A. SERJEANTSON, S.W. see JAZWINSKA, E.C. PepINI, B. see BAGNASCO, M. SERRE, A. see VENDRELL, J.P. Peprosa, J.M. see APPELBERG, R. SHANAHAN, F. see Deem, R.L. PELTON, B.K., SPECKMAIER, M., HYLTON, W., FARRANT, J. & DENMAN, SHELDON, J. see HENDERSON, D. A.M. Cytokine-independent progression of immunoglobulin produc- SHEPHERD, P.S. see Ox.ey, J.D. tion in vitro by B lymphocytes from patients with systemic lupus SHiMIzu, F. see Morioka, T. erythematosus, 274 Suimizu, F. see Narita, I. PIDDLESDEN, S., LASSMANN, H., LAFFAFIAN, I., MORGAN, B.P. & Sitva, M.T. see APPELBERG, R. LININGTON, C. Antibody-mediated demyelination in experimental SINGH, V.K. see WARREN, R.P. allergic encephalomyelitis is independent of complement membrane So, A.K. L. see Howe, H.S. attack complex formation, 245 SODERSTROM, R. see NILSsSEN, D.E. PINGREE, C.B. see WARREN, R.P. SODERSTROM, T. see NILSSEN, D.E. PomaT, W. see Witt, C.S. SOUCHE, S. see BOYER, V. PONARD, D. see WURZNER, R. SPATH, P. see WURZNER, R. PoTTER, P. see WURZNER, R. SPECKMAIER, M. see PELTON, B.K. Potts, A.J. C. see DEACON, E.M. Spiteri, M.A. & PouLTer, L.W. Characterization of immune inducer PouLTer, L.W. see Spiteri, M.A. and suppressor macrophages from the normal human lung, 157 POVERENNY, A.M. see KABAKOV, A.E. STAINES, N.A. see MORLAND, C. Puri, R.K., LELAND, P. & RAzzaque, A. Antigen(s)-specific tumour- STAINES, N.A. see WATTS, R.A. infiltrating lymphocytes from tumour induced by human herpes STAMATAKIS, G. see CHOLLET-MARrRTIN, S. virus-6 (HHV-6) DNA transfected NIH 3T3 transformants, 96 STEEL, C.M. see DEANE, D.L. PuRTLO, D.T. see YASUDA, N. STEWART, C. see HAMILTON, F. STRAIN, J.J. see MARTIN, S.J. QuinTI, I. see LE Mout, S. STRAYER, D.S., HALLMAN, M. & Merrit, T.A. Immunogenicity of surfactant.I. Human alveolar surfactant, 35 RADL, J. see MULLER, F. STRAYER, D.S., HALLMAN, M. & Merrit, T.A. Immunogenicity of RAMDAHIN, R. see WATSON, W. surfactant. II. Porcine and bovine surfactants, 41 RAVIRAJAN, C.T. see Watts, R.A. STROFFOLINI, T. see LE MOLI, S. RAYFIELD, L.S. see Oxey, J.D. Sunpin, U. & SuNDQvist, K.G. Plasma membrane association of Raynes, J.G., EAGLING, S. & Mcapam, K.P. W. Acute-phase protein primary biliary cirrhosis mitochondrial marker antigen M2, 407 synthesis in human hepatoma cells: differential regulation of serum SUNDOVIST, K.G. see SUNDIN, U. amyloid A (SAA) and hepatoglobin by interleukin-| and interleukin-6, SurcEL, H.-M. see SYRJALA, H. 488 SurceL, H.M., TAPANINAHO, S. & HERvA, E. Cytotoxic CD4* T cells RAZZAQUE, A. see Puri, R.K. specific for Frabcisella tularensis, 112 REICHLIN, M. & VAN VENROOUW, W.J. Autoantibodies to the URNP SuZuKI, N. see NISHIKAWA, K. particles: relationship to clinical diagnosis and nephritis, 286 SyRJALA, H., SURCEL, H.-M. & ILONEN, J. Low CD4/CD8 T lymphocyte Reynes, J. see VENDRELL, J.P. ratio in acute myocardial infarction, 326 REYNOLDS, S.P. see JONES, K.P. Ricci, G.L. see BIANCONE, L. Ricues, P. see HENDERSON, D. TAKEDA, K. see IKEDA, M. RieGer, C.H.L. see SCHUER, U. TAMAI, H. see NISHIKAWA, K. Roserts, J.E. see OGAwa, T TANIGUCHI, N. see MIYAWAKI, T. RosBinson, B.S. W. see MANNING, L.S. TAPANINAHO, S. see SURCEL, H.M. Rocers, J. see YASUDA, N. TARGAN, S.R. see DEM, R.L. Roursacnu, M.S. & Conrap, A.K. Comparison of the T lymphocyte- *T Hart, B.A., BoTMAN, C.A.D. & BAKKER, N.P.M. Induction of type dependent induction of angiotensin-converting enzyme and leucine II collagen-specific antibody production in blood lymphocyte cul- aminopeptidase in cultured human monocytes, 510 tures of Rhesus monkeys (Macaca mulatta) with collagen-induced Rooney, I.A., Davies, A., GrirriTHs, D., WiLLiaMs, J.D., Davies, M., arthritis using the immobilized native antigen, 375 Meri, S., LACHMANN, P.J. & MorGAn, B.P. The complement- THE, T.H. see VAN ZANTEN, J. inhibiting protein, Protectin (CD59 antigen), is present and functio- Tuomas, P.S. see ROTHER, R.P. nally active on glomerular epithelial cells, 251 Tomizawa, K., ISHIZAKA, A., Kosyima, K., MAKANISHI, M., SAKIYAMA, Rossi, F., JayNe, D.R. W., Lockwoop, C.M. & KAZATCHKINE, M.D. Y. & Matsumoto, S. Interleukin-4 regulates the interleukin-2 Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoanti- receptors on human peripheral blood B lymphocytes, 492 bodies in normal human polyspecific IgG for therapeutic use and in TonGio, M.M. see URLACHER, A. the remission sera of patients with systemic vasculitis, 298 TOOMATH, R. see KONTIAINEN, S. Rossier, H. see Boyer, V. Tooze, J.A. & Bevan, D.H. Decreased expression of complement RoTHER, R.P. & THomas, P.S. La/SSB ribonucleoprotein levels receptor type 2 (CR2) neoplastic B cells of chronic lymphocytic increased in transformed cells, 369 leukaemia, 423 Author Index 523 URBAIN, J. see DOUTRELEPONT, J.M. Watts, R.A., RAVIRAJAN, C.T., WILKINSON, L.S., WILLIAMS, W., Ursaln, J. see WissinG, M. GriFFiTHs, M., BUTCHER, D., HorsFALL, A.T., STAINES, N.A. & URLACHER, A., TONGIO, M.M. & PASQuaL_t, J.L. lgM anti-idiotypes that ISENBERG, D.A. Detection of human and murine common idiotypes of block anti-HLA antibodies: naturally occurring or immune anti- DNA antibodies in tissues and sera of patients with autoimmune bodies?, 116 diseases, 267 WessterR, A.D.B. see Howe, H.S. VALENTINI, R.A. see MANTOVANI, V. Wuite, D.G. Editorial review: FK 506: the promise and the paradox, | VAN Der Bu, W. see VAN ZANTEN, J. Wuite, E. see WARREN, R.P. VAN Der GIESSEN, M. see BROUWER, E. WICKRAMASINGHE, S.N. see WIENER, E. VAN Der GIESSEN, M. see VAN ZANTEN, J. WIENER, E. & WICKRAMASINGHE, S.N. Natural antibodies may play a VANDERHAEGEN, M.L. see DOUTRELEPONT, J.M. role in ineffective erythropoiesis during megaloblastic haemopoiesis, VAN Der Voort, L.H. M. see VAN ZANTEN, J. 121 VAN ELSEN, P.J. see VAN Laar, J.M. WILKINSON, L.S. see WaTTs, R.A. VAN Laar, J.M., MILTENBURG, A.M.M., VERDONK, M.J.A., Dana, WILuiaAMS, J.D. see ROONEY, I.A. M.R., De Vries, R.R.P., VAN ELsEN, P.J. & BREEDVELD, F.C. Lack of WILLIAMS, W. see WaTTS, R.A. T cell oligoclonality in enzyme-digested synovial tissue and in WILSON, G. see GALLAGHER, G. synovial fluid in most patients with rheumatoid arthritis, 352 WissinG, M., MARCHANT, A., Moser, M., FLAMAND, V., Leo, O., VAN Son, W.J. see VAN ZANTEN, J. ABRAMOWICZ, D., URBAIN, J. & GOLDMAN, M. Modulation of murine VAN VENROOU, W.J. see REICHLIN, M. F host-versus-graft disease by anti-CD3 monoclonal antibody, 333 VAN ZANTEN, J., VAN DeR GiESSEN, M., VAN Der Voort, L.H.M., Witt, C.S., PomMat, W., LEHMANN, D. & ALPeRs, M.P. Antibodies to VAN Son, W.J., VAN Der Bu, W. & Tue, T.H. Cytomegalovirus- pneumococcal polysaccharides in pneumonia and response to pneu- specific antibodies to an immediate early antigen and a late membrane mococcal vaccination in young children in Papua New Guinea, 219 antigen and their possible role in controlling secondary cytomegalo- Wonca, S., Moore, S., Orisio, S., MILLWARD, A. & DemaINg, A.G. virus infection, 102 Susceptibility to type I diabetes in women is associated with the CD3 VeBER, M.B., CUNNINGHAM-RUNDLES, S., SCHULMAN, M., MANDEL, F. epsilon locus on chromosome 11, 69 & AuLp, P.A.M. Acute shift in immune response to microbial WUrRZNeER, R., ORREN, A., PoTTER, P., MORGAN, B.P., PONARD, D., activators in very-low-birth-weight infants, 391 SpATH, P., Bral, M., ScHuLzE, M., Happs, L. & Gértze, O. VENDRELL, J.P., SEGONDY, M., Ducos, J., REyNes, J., HUGUET, M.F., Functionally active complement proteins C6 and C7 detected in C6- Nico as, J.C. & SERRE, A. Analysis of the spontaneous in vitro anti- and C7-deficient individuals, 430 HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection, 197 YACHIE, A. see MIYAWAKI, T. VERDONK, M.J. A. see VAN Laar, J.M. Yasuba, N., Lai, P.K., RoGers, J. & PuRTLO, D.T. Defective control of Vinas, O. see MUNOZ, A. Epstein-Barr virus-infected B cell growth in patients with X-linked VoLk, H.D. see JAHN, S lymphoproliferative disease, 10 VON BAEHR, R. see JAHN, S. Yoxol, T. see MiyAwakI, T. YosuipA, A. see KimaTA, H. WALSH, L.P. see GALLAGHER, G. WANG, C.C. see Le!, H.Y. ZaGurRY, D. see BOYER, V. WANG, J.Y. see Lei, H.Y. ZAULI, D. see FUSCONI, M. WarREN, R.P., SINGH, V.K., CoLe, P., ODELL, J.D., PINGREE, C.B., ZHENG, R.Q. H., ApBNey, E., Cuu, C.Q., Fietp, M., GRUBECK- WarrEN, W.L. & Wuite, E. Increased frequency of the null allele at LOBENSTEIN, B., MAINI, R.N. & FELDMANN, M. Detection of inter- the complement C4b locus in autism, 438 leukin-6 and interleukin-1 production in human thyroid epithelial WARREN, W.L. see WARREN, R.P. cells by non-radioactive in situ hybridization and immunohistochemi- Watson, W., OEN, K., RAMDAHIN, R. & HARMAN, C. Immunoglobulin cal methods, 314 and cytokine production by neonatal lymphocytes, 169 Subject Index 14C1, 92 DR* T cells, 396 AIDS, 192, 203, 452 DTT cytotoxicity technique, 116 ANCA, 379 Decay-accelerating factor, 364 Activation, 175 Delayed-type hypersensitivity, 137 Acute-phase protein, 488 Demyelination, 245 Adhesion molecules, 309 Dense deposits, 143 Adult periodontitis, 237 Allergy, 25 Early-type hypersensitivity, 210 American cutaneous leishmaniasis, 472 Epstein-Barr virus, 187, 447 Angiotensin-converting enzyme, 510 Erythropoietin, 483 Anti-CD3 monoclonal antibodies, 333 Experimental allergic encephalitis, 245 Anti-HLA antibodies, 116 Anti-IEA antibodies, 102 FK506, | Anti-MPO antibodies, 379 Fc receptor, 47 Anti-idiotype, 126 Fibronectin, 58 Anti-nuclear antibodies, 291 Fimbriae, 237 Anti-surfactant antibodies, 35, 41 Flow cytometry, 423 Antibodies, 197 Francisella tularensis, 112 Antibody clonotypes, 460 Function, 157 Antibody production, 375 Fungicidal activity, 225 Antibody secretion, 163 Antigen presentation, 505 Germinal centres, 262 Apoptosis, 338 Glomerular epithelial cells, 251 Asbestos, 85 Glomerulonephritis, 497 Asthma, 25 Glycoprotein 63, 472 Atopic dermatitis, 25 Glycosaminoglycans, 497 Autantibodies, 407 Graft-versus-host disease, 133 Autism, 438 Granulocyte-macrophage colony-stimulating factor, 225 Autoantibodies, 137, 291 Granulocytes, 231 Autoimmune orchitis, 137 Granulocytosis, 231 Autoimmunity, 64, 298, 309, 333 Graves’ disease, 309 B cell repertoire, 262 HBsAg, 210 B cells, 175, 274, 280 HHV-6, 96 B-CLL, 423 HIV, 203 Bone marrow, 163 HIV-1, 187, 197 Bronchoalveolar lavage, 30 HIV-1I envelope, 452 HLA, 74 C4, 387 HLA-D, 387 C4B, 438 Haemodialysis, 329 C6, 430 Haptoglobin, 488 C7, 430 Hashimoto's thyroiditis, 309 CD45, 175 Heliobacter pylori, 396 CD45RO, 447 Heymann’s nephritis, 143 CDS B lymphocytes, 304 Human cartilage degradation, 52 CDS5* Bc ells, 413 Human monoclonal antibodies, 92, 413, 452 CR2 (CD21), 423 Human monocytes, 182 Ca**, 149 Human peripheral blood B lymphocytes, 492 Cancer immunotherapy, 96 Hyper IgE, 133 Cell-mediated bacterial immunity, 112 Hypoferraemia, 215 Chronic lymphocytic leukaemia, 413 Class II MHC, 64 Idiotypes, 298 Coeliac disease, 74 IgA subclass, 203 Complement deficiency, 430 IgA subclasses, 237 Complement, 245, 251, 438 IgE production, 483 Cord B and T lymphocytes, 169 IgE, 163 Crohn’s disease, 320, 401 IgG subclass deficiencies, 17 Cross-reactive idiotopes, 280 IgG subclasses, 237, 379 Cryoimmunoglobulins, 58 IgG, 30 Cytokine production, 169 IgM anti-idiotypic antibodies, 116 Cytokines, 215, 274, 314, 396, 466, 479 IgM, 203 Cytomegalovirus, 102 Immune complexes, 359, 364 Cytotoxicity, 112, 154 Immune sera, 210 Immunodeficiency, 17, 387 DNA antibody idiotypes, 267 Immunoglobulin production, 274 DNA synthesis, 149 Immunoglobulin synthesis, 169 Subject Index Immunoglobulin-producing cells, 17 Necrosis, 338 Immunohistochemistry, 314, 364 Neonatal respiratory stress syndrome, 41 Immunomodulation, 466 Neonatal tolerance, 333 Immunophenotypic analysis, 418 Neopterin, 479 Immunosuppressant, 126 Neural cell adhesion molecule, 418 Immunotherapy, 92 Neutrophils, 225 In vitro, 510 Non-radioactive in situ hybridization, 314 Ineffective erythropoiesis, 121 Null alleles, 438 Infectious mononucleosis, 447 Inflammation, 245 Oligoclonality, 352 Inflammatory bowel disease, 320 Ovarian cancer, 92 Insulin autoantibodies, 304 Insulin-dependent diabetes mellitus, 347 Polymerase chain reaction, 74 Interferon, 479 Papua New Guinea, 219 Interferon-gamma, 10, 64, 79, 492 Periodontal disease, 108 Interleukin-1, 52, 149, 182, 192, 488 Periodontopathic bacteria, 108 Interleukin-2 receptor, 401 Peripheral blood mononuclear cells, 197, 375 Interleukin-2 receptor-positive T cells, 396 Phenotype, 441 Interleukin-2 receptors, 492 Phenotypes, 157 Interleukin-2, 85, 96, 401 Phytohaemagglutinin, 391 Interleukin-4, 133, 483, 492 Plasma membrane, 407 Interleukin-6, 30, 488 Pneumococcus, 219 Intracellular bacteria, 112 Pneumonia, 219 Intravenous immunoglobulins, 298 Polysaccharide antigen, 219 Islet cell autoantibodies, 304 Porphyromonas (Bacteroides) gingivalis, 237 Post-viral fatigue syndrome, 441 Japanese encephalitis virus, 215 Primary biliary cirrhosis, 291, 407 Protectin, 251 La/SSB, 396 Protein—protein interactions, 58 Lactoferrin, 154 Passive immunotherapy, 452 Lamina propria lymphocytes, 79 Leishmania, 472 Radioassay, 257 Leucine-converting enzyme, 510 Radioimmunoassay, 30 Leucine methyl ester, 505 Reactive arthritis, 516 Lipophosphoglycan, 472 Respiratory burst, 225 Low-density lipoprotein, 359 Respiratory stress syndrome, 35 Lung, 35 Restriction fragment length polymorphism, 47, 74 Lymphocyte proliferation, 108 Rheumatoid arthritis, 52, 352, 364 Lymphocyte subsets, 25, 326 Rheumatoid factors, 280 Lymphocytes, 401 Lymphokine-activated killer cells, 85 Salivary glands, 280 Lysosomal enzymes, 225 Scleroderma, 47 Secretion, 197 Macrophage-derived factor, 215 Secretory IgA, 203 Macrophages, 157 Serum amyloid A, 488 Male infertility, 137 Sjégren’s syndrome, 267, 280, 369 Malignant mesothelioma, 85 Staphylococcal protein A, 391 Megaloblastic haemopoiesis, 121 Suppressor lymphocytes, 320 Membrane attack complex, 251 Suppressor T cells, 10 Membrane co-factor protein (CD46), 257 Surfactants, 35, 41 Meningococcal polysaccharide A, 460 Synovial cell lining, 364 Meningococcal polysaccharide C, 460 Synovial fluid, 52 Mesangial cells, 149, 182, 497 Systemic lupus erythematosus, 47, 267, 274, 286, 359 Mitochondrial antigen M2, 407 Systemic vasculitis, 298 Mixed connective tissue disease, 286 Mixed lymphocyte cultures, 479 Molecular fractions, 108 T cell activation, 79, 447 Monoclonal antibodies, 143, 157 T cell clones, 505 Monocytes, 154, 329, 497, 510 T cell receptor usage, 345, 347 Monokines, 192 T cell repertoire, 108 Mucosal immunity, 17 T cells, 352 Multiple myeloma, 418 T lymphocytes, 510 Murine lupus, 126 Testes, 137 Myasthenia gravis, 262 Thymus, 262 Mycobacterial infection, 231 Thyroid epithelial cells, 314 Mycobacterium avium, 231, 466 Thyroid, 64, 309 Mycobacterium paratuberculosis, 320 Tumour necrosis factor-alpha, 52, 79, 192, 329, 516 Myocardial infarction, 326 Tumour-infiltrating lymphocytes, 96 Type I (insulin-dependent) diabetes, 304 Type II collagen, 375 Nasal and rectal mucosa, 17 Natural antibodies, 413 Natural autoantibodies, 121 URNP, 286 Natural killer cells, 85, 154, 441 Ulcerative colitis, 320 526 Subject Index Vaccination, 219 X inactivation, 4 Very-low-birth-weight infants, 391 X-linked lymphoproliferative disease, 10 X-linked severe combined immunodeficiency, 4 Wegener's granulomatosis, 379 Western blot, 291, 407 Zinc deficiency, 338